Investigators in the Division of Infectious Diseases are poised to advance our current clinical knowledge and translational basic research in infectious diseases. Division faculty are already on the front lines of major research.
National HIV/AIDS experts head the Division's AIDS Clinical Trials Unit (ACTU), an NIH-funded research site that continues to augment the medical community's knowledge about new treatment for persons with HIV/AIDS. Investigators in our Pharmaceutical Studies are pursuing "medicines of the future" that will aid in the prevention and treatment of infectious diseases. Working closely with joint faculty members in the Department of Microbial Infections & Immunity, the division collaborates on project of microbial pathogenesis research.
Many of our studies are aimed at intergrating clinical medicine and basic science. The following are among some of the Division's major efforts and their lead investigators:
AIDS Clinical Trials Unit/Clinical Studies in HIV/AIDS - Susan L. Koletar, MD, Michael Para, MD
HIV, Mother to Child Transmission - Jesse Kwiek, PhD
Sexually Transmitted Infections - Abigail Norris Turner, PhD, Jose Bazan, DO
Clinical Epidemiology, Infections Control - Julie E. Mangino, MD
Antimicrobial Stewardship and Resistance - Kurt B. Stevenson, MD, MPH
Locan and International Tuberculosis - Shu Hua Wang, MD, MPH, TM
Leishmania and Trypanosome Pathogenesis - Bradford S. McGwire, MD, PhD
Mycobacterium Tuberculosis Bacillus - Jordi B. Torelles, PhD
Infections in Transplant Recipients - Stephanie Pouch, MD, MS, Nicole Theodoropoulos, MD, MS
Immune System and Aging - Joanne Turner, PhD
Mycobacterial Pathogenesis - Larry S. Schlesinger, MD